The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Workspace mulls selling former McKay assets

Fri, 27th May 2022 07:44

(Alliance News) - Stock prices in London are seen opening lower on Friday, failing to follow the lead of a rally in New York overnight, but still on track for a weekly gain.

In early UK corporate news, pharmaceutical firm GSK said watchdogs in China backed a two-dose vaccine to treat cancer-causing human papillomavirus. Stagecoach has agreed to buy east London bus operations, while Workspace is mulling selling light industrial assets formerly owned by recently-acquired McKay.

IG futures indicate the FTSE 100 index is to open down 27.0 points, 0.4%, at 7,537.92. The blue-chip index closed up 42.17 points, or 0.6%, at 7,564.92 on Thursday. Since last Friday, London's flagship index has advanced 2.4%.

While the FTSE was called lower, other markets were more positive. Asian stocks were largely higher on Friday, while Wall Street closed strongly on Thursday.

In Tokyo on Friday, the Nikkei 225 ended up 0.7%. The Shanghai Composite was marginally higher in late trade, while the Hang Seng in Hong Kong was 2.0% higher. The S&P/ASX 200 added 1.1%.

The Dow Jones Industrial Average finished up 1.6%, the S&P 500 up 2.0% and the Nasdaq Composite up 2.7%.

"US indices gained for the second day as the FOMC minutes helped improving the investor mood. Fed minutes released on Wednesday weren't as hawkish as many investors feared: the Fed deciders mostly agreed that inflation is too high and labour market is too tight and that they should raise the rates by 50bps for the next two meetings. But, there was no sign that the Fed would go down the 75bp hike road. Some members thought the price pressures won't get much worse, and the Atlanta Fed President [Raphael] Bostic even suggested that, given that economic data has taken a step backward, the central bank could even pause on rate hikes in September," Swissquote analyst Ipek Ozkardeskaya commented.

GSK said China's National Medical Products Administration has approved a two-dose vaccine schedule for Cervarix to be administered to girls aged between 9 and 14. The jab prevents certain types of cancer-causing human papillomavirus, a viral condition.

The green light adds to two-dose approvals in roughly 100 other countries, including in the European Union, Asia, Africa, and Latin America.

Earlier in May, the company formally changed its name to GSK from GlaxoSmithKline.

The west London-based firm at the time added that it is still proceeding with the demerger of its Consumer Healthcare business, which was first started in early 2020 and is expected to be completed in July.

FTSE 250-listed Workspace is considering disposing of the light industrial assets that were formerly owned by McKay. Workspace sealed the acquisition of property firm McKay earlier in May for GBP272 million.

Workspace, real-estate investment trust, on Friday said it has "received unsolicited indications of interest from a number of parties" for the portfolio of light industrial assets.

"Workspace confirms that it is now considering disposing of the light industrial assets," Workspace explained.

Following the completion of the McKay acquisition, Workspace's portfolio consisted of GBP2.9 billion worth of gross property assets, with 5.5 million square feet of lettable space.

Buying up assets, meanwhile, was transport firm Stagecoach, itself set to be taken over.

Stagecoach has entered into binding agreements to acquire Kelsian Group's east London bus operations and depot at Lea Interchange for GBP20 million.

"Upon completion, GBP10 million will be payable, with a further GBP1 million per annum payable for ten years commencing on the first anniversary following completion, subject to certain conditions," Stagecoach explained.

"The acquisition is a good strategic fit with Stagecoach's existing operations in east and south-east London. Lea Interchange depot is well located close to Stratford, the busiest station in the UK."

The new acquisition operates 11 contracts on behalf of Transport for London. It has an annual revenue of GBP38 million.

On Thursday, Stagecoach said its shares are to be cancelled by June 27. Earlier in May, Pan-European Infrastructure III SCSp, an infrastructure fund managed by DWS Infrastructure, said its GBP594.9 million offer for Stagecoach became unconditional.

Elsewhere in London, car dealer Caffyns resumed paying a final dividend, amid annual earnings growth, but cautioned on supply chain worries and UK consumer confidence.

In the financial year that ended March 31, revenue climbed 36% to GBP223.9 million from GBP165.1 million. Pretax profit jumped to GBP4.4 million from GBP1.4 million.

Caffyns declared a final dividend of 15.0 pence per share. Its annual payout totals 22.5p. It did not pay a dividend in financial 2021.

Chief Executive Simon Caffyn commented: "The underlying profit before tax of GBP4.6 million was a significant improvement on the prior year. Despite limited new car supply, operating profits improved due to very buoyant trading in used cars and our strong focus on improving operational effectiveness."

The company said it has kicked off the new year with "a sense of optimism" but it is "mindful" of supply chain disruption and consumer confidence.

The pound was quoted at USD1.2633 early Friday in London, up from USD1.2580 at the London equities close on Thursday.

The euro stood at USD1.0751, higher from USD1.0725. Against the yen, the dollar was trading at JPY126.88, fading from JPY127.37.

Still to come in Friday's economic events calendar is the latest US personal consumption expenditure price data at 1330 BST. The core index reading is the Fed's preferred gauge of inflation.

"Personal income & expenditure and the PCE index could settle nerves on inflation and Fed tightening if they print on the low side," Oanda analyst Jeffrey Halley commented.

According to FXStreet-ctied consensus, annual PCE inflation is expected to be stable at 6.6% in April. Core PCE inflation is forecast to slow to 4.9% from 5.2%.

Brent oil quoted at USD117.07 a barrel early Friday in London, flat from USD117.05 late Thursday. Gold stood at USD1,856.37 an ounce, up from USD1,846.75.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.